0.50Open0.50Pre Close0 Volume3 Open Interest61.00Strike Price0.00Turnover287.15%IV24.60%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type-0.0670Delta0.0083Gamma160.48Leverage Ratio-0.4551Theta-0.0003Rho-10.75Eff Leverage0.0071Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet